Ikena Oncology, Inc.IKNANASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank14
3Y CAGR-21.7%
5Y CAGR-13.2%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-21.7%/yr
vs +69.9%/yr prior
5Y CAGR
-13.2%/yr
Recent deceleration
Acceleration
-91.6pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$82.81M-41.5%
2024$141.51M-26.3%
2023$192.09M+11.5%
2022$172.26M-30.5%
2021$247.88M+47.2%
2020$168.40M+95.9%
2019$85.97M+315.8%
2018$20.68M-